ARCHIVES

The Antineoplaston Anomaly: How A Drug Was Used For Decades In Thousands Of Patients, With No Safety, Efficacy Data

This article is from The Cancer Letter archive.

Vol. 24 No. 36 | September 25, 1998

Download PDF Visit The Full Archive

Related Articles

Three Genetics Pioneers Win Nobel Prize

October 11, 2002

NCA Urges Pay Line Adjustment To Cut Back On Grant Duplications

October 10, 1980

DCBD Board Like Organ Systems Program But Not RFAs, Okays Program Announcement, Contract Concepts

November 20, 1987

In Brief: Ways & Means Shakeup Means More Liberal Health Insurance Bill; OMB’s Nutty Rational For Cuts

December 20, 1974

HHS Forms Rural Task Force To Study, Improve Programs.

July 27, 2001

Cancer Clinical Trials System Needs Comprehensive Review, NCI Director Says

July 11, 2003